logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Masatoshi Kudo

kindai university faculty of medicine

143H-index
2.8KPaper Count
12.5WCitation Count
Published Papers 895
Publication Date
logo
First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study
errJournal of Hepatology
IF33
err2026-10-06
err0
PREAI
errStephen L. Chan; Masatoshi Kudo; Bruno Sangro; Robin Kate Kelley; Jee Hyun Kim; Binh Pham; Jung Yong Hong; Dirk-Thomas Waldschmidt; Donatella Marino; René Gerolami; Adam M. Burgoyne; Gianluca Masi; Robert John Walsh; Jens U. Marquardt; Ugochinyere Emeribe; Kavitha Balaji; Peng Sun; Boris Baur; Lorenza Rimassa
errShare
errSave
Clinical utility of serum leucine-rich alpha-2 glycoprotein for assessing disease activity and mucosal healing in ulcerative colitis across different treatment settings: a prospective observational cohort study
errBMC Gastroenterology
IF2.6
err2026-09-29
err0
errOAAI
errMasashi Kono; Yoriaki Komeda; Tomoyuki Nagai; Kohei Handa; Saki Yoshida; George Tribonias; Satoru Hagiwara; Shunsuke Omoto; Mamoru Takenaka; Hiroshi Kashida; Masatoshi Kudo
errShare
errSave
Multiple Modes of Action of Anti-TNF-α Antibodies for Inflammatory Bowel Diseases Beyond TNF-α Neutralization
errAntibodies
IF2.7
err2026-09-21
err0
errOAAI
errTomohiro Watanabe; Masatoshi Kudo
errShare
errSave
Nucleotide-binding oligomerization domain 2-independent colonization by Turicimonas muris induced by high-fat diet protects against dextran sodium sulfate-induced colitis
errClinical and Experimental Immunology
IF3.8
err2026-09-12
err0
errOAAI
errHajime Honjo; Tomohiro Watanabe; Yasuo Otsuka; Yasuhiro Masuta; Sho Masaki; Ken Kamata; Kosuke Minaga; Seiichi Omura; Ah-Mee Park; Masatoshi Kudo; null
errShare
errSave
Toward Global Harmonization of EUS-Guided Biliary Drainage: A Step Beyond Regional Consensus
errDigestive Endoscopy
IF4.7
err2026-09-01
err0
PREAI
errKosuke Minaga; Masatoshi Kudo
errShare
errSave
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study
errLancet Oncology
IF35.9
err2026-08-24
err0
PREAI
errMasatoshi Kudo; Ghassan K Abou-Alfa; Zhenggang Ren; Jeong Heo; Riccardo Lencioni; Yasuaki Arai; Mohamed Bouattour; Maria A Gonzalez-Carmona; Yabing Guo; Ai-Bing Xu; Gustavo Vasconcelos Alves; Arunee Dechaphunkul; Gwo Fuang Ho; Yueh Ni Lim; HongTao Hu; Ruibao Liu; Shanzhi Gu; Vikas Ostwal; Witsarut Manasirisuk; Chang-Fang Chiu
errShare
errSave
Beyond Equivalence: Reconsidering the Role of EUS-Guided Gallbladder Drainage in the Post-ERCP Failure Algorithm
errDigestive Endoscopy
IF4.7
err2026-05-29
err0
PREAI
errKosuke Minaga; Masatoshi Kudo
errShare
errSave
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma
errHepatology Research
IF3.4
err2026-05-11
err0
PREAI
errKazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
errShare
errSave
Plain language summary of five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (liver cancer)
errFuture Oncology
IF2.6
err2026-05-10
err0
errOAAI
errLorenza Rimassa; Stephen L. Chan; Bruno Sangro; George Lau; Masatoshi Kudo; Maria Reig; Valeriy Breder; Min-Hee Ryu; Yurii Ostapenko; Wattana Sukeepaisarnjaroen; Maria Varela; David Tougeron; Oxana V. Crysler; Mohamed Bouattour; Tu Van Dao; Vincent C. Tam; Adilson Faccio; Junji Furuse; Long-Bin Jeng; Yoon Koo Kang; Robin K. Kelley; John F. Kurland; Kavitha Balaji; Ghassan K. Abou-Alfa
errShare
errSave
Diagnostic Utility of Endoscopic Features and Endoscopic Ultrasonography for Ulcerative Colitis-Associated Neoplasia: A Retrospective Study on the Role of Endoscopic Submucosal Dissection as a Total Biopsy
errCancers
IF4.4
err2026-05-07
err0
errOAAI
errSaki Yoshida; Yoriaki Komeda; Masashi Kono; Kohei Handa; Tomoyuki Nagai; Satoru Hagiwara; Shunsuke Omoto; Mamoru Takenaka; Hiroshi Kashida; George Tribonias; Koji Daito; Junichiro Kawamura; Masatoshi Kudo
errShare
errSave
Real-World Evidence from a Nationwide Prospective Study of the Efficacy/Safety of Systemic Therapy for Unresectable Hepatocellular Carcinoma: First 1,000 Patients of the PRISM Study
errLiver Cancer
IF9.1
err2026-05-01
err0
PREAI
errIkeda, Masafumi; Itoh, Shinji; Onozuka, Daisuke; Ogasawara, Sadahisa; Kawaoka, Tomokazu; Niizeki, Takashi; Yamashita, Taro; Tanaka, Yasuhito; Yamada, Tomoharu; Numata, Kazushi; Tateishi, Ryosuke; Yamashita, Tatsuya; Okusaka, Takuji; Furuse, Junji; Kudo, Masatoshi
errShare
errSave
Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer
errIn Vivo
IF1.8
err2026-05-01
err0
PREAI
errFujihara, Daisuke; Honjo, Hajime; Masuta, Yasuhiro; Otsuka, Yasuo; Masaki, Sho; Minaga, Kosuke; Kamata, Ken; Tsuji, Naoko; Watanabe, Tomohiro; Kudo, Masatoshi
errShare
errSave
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
errHepatology Research
IF3.4
err2026-04-21
err0
PREAI
errFujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
errShare
errSave
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab
errHepatology Research
IF3.4
err2026-04-10
err0
PREAI
errKazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
errShare
errSave
No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errKazuomi Ueshima; Naoshi Nishida; Satoru Hagiwara; Yasunori Minami; Hiroshi Ida; Masahiro Takita; Hirokazu Chishina; Masahiro Morita; Tomoko Aoki; Tetsutaro Hamano; Ryosuke Take; Chizuko Watanabe; Kohsuke Asoh; Ai Tanaka; Masatoshi Kudo
errShare
errSave
Roles of Deubiquitinases OTUD3 and OTUD5 in Inflammatory Bowel Diseases
errInternational Journal of Molecular Sciences
IF4.9
err2026-03-03
err0
errOAAI
errTomohiro Watanabe; Masatoshi Kudo
errShare
errSave
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
errLiver International
IF5.2
err2026-02-26
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
errShare
errSave
Pattern of progression and post-progression survival following transarterial embolization. A analysis of the TACE-2 and TACTICS trials.
errJHEP Reports
IF7.5
err2026-02-25
err0
errOAAI
errJack Shi Jie Yuan; Memuna Rashid; Kazuomi Ueshima; Andre Lopes; Yuk Ting Ma; Paul Ross; Daniel Palmer; Masatoshi Kudo; Tim Meyer
errShare
errSave
Impact of Early-Line Systemic Therapies on Liver Function in Hepatocellular Carcinoma: Longitudinal Change of ALBI Score and Ammonia Level With and Without Anti-VEGF Agents
errHepatology Research
IF3.4
err2026-01-25
err0
errOAAI
errNaoshi Nishida; Kazuomi Ueshima; Tomoko Aoki; Takuya Matsubara; Naoya Omaru; Natsuki Okai; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Yasunori Minami; Masatoshi Kudo
errShare
errSave
Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma
errJournal of Hepatology
IF33
err2026-01-22
err0
PREAI
errAdam Yopp; Minshan Chen; Ann-Lii Cheng; Ahmed Kaseb; Masatoshi Kudo; Han Chu Lee; Edward Cha; Stephen Paul Hack; Qinshu Lian; Jessica Spahn; Chun Wu; Shukui Qin; Pierce Kah-Hoe Chow
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
J
Josep M. Llovet
H-index: 151 · Papers: 794
M
Masao Omata
H-index: 133 · Papers: 1.7K
K
Kazuaki Chayama
H-index: 129 · Papers: 2.6K
J
Jordi Bruix
H-index: 128 · Papers: 705
P
Peter R. Galle
H-index: 128 · Papers: 2.4K
View more